Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,965 | -2,391 | -1,264 | -3,252 | -2,329 |
| Depreciation Amortization | 146 | 85 | 37 | 99 | 79 |
| Accounts receivable | 377 | 330 | 309 | -1,094 | -560 |
| Other Working Capital | 1,017 | 1,186 | 1,076 | -934 | -807 |
| Other Operating Activity | 421 | -42 | -172 | 1,176 | 582 |
| Operating Cash Flow | $-2,005 | $-832 | $-14 | $-4,005 | $-3,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -321 | -268 | -183 | -349 | -325 |
| Investing Cash Flow | $-321 | $-268 | $-183 | $-349 | $-325 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,300 | 1,300 | N/A | 162 | 162 |
| Debt Repayment | -28 | -19 | -9 | -43 | -28 |
| Common Stock Issued | 86 | 86 | N/A | 25 | 25 |
| Dividend Paid | -140 | -140 | -140 | N/A | N/A |
| Other Financing Activity | 4,350 | 930 | 997 | 4,407 | 4,519 |
| Financing Cash Flow | $5,567 | $2,157 | $848 | $4,551 | $4,678 |
| Beginning Cash Position | 232 | 232 | 232 | 35 | 35 |
| End Cash Position | 3,474 | 1,289 | 882 | 232 | 1,353 |
| Net Cash Flow | $3,242 | $1,057 | $650 | $197 | $1,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,005 | -832 | -14 | -4,005 | -3,035 |
| Capital Expenditure | -321 | -268 | -183 | -349 | -325 |
| Free Cash Flow | -2,326 | -1,100 | -198 | -4,354 | -3,359 |